Download PDF
ZWR - Das Deutsche Zahnärzteblatt 2013; 122(12): 634-637
DOI: 10.1055/s-0034-1368155
Fortbildung
Umweltzahnmedizin
© Georg Thieme Verlag Stuttgart · New York

Depression und Fatigue bei chronischer Entzündung – Welchen Einfluss haben zahnärztliche Maßnahmen?

K Huesker
Further Information

Publication History

Publication Date:
25 January 2014 (online)

Also available at
    Permissions and Reprints

In Abhängigkeit der individuellen Suszeptibilität kann die Fremdstoffbelastung aus Zahnersatzmaterialien Trigger für chronische Entzündungen setzen, die von Symptomen aus dem depressiven Formenkreis begleitet werden. Dabei spielen Sensibilisierungen ebenso wie immuntoxische Reaktionen auf die im Mund freigesetzten Metalle, Kunststoffe und Einweißzerfallsprodukte eine wichtige Rolle. Der Zusammenhang zwischen Depression, Fatigue und Entzündung ist auf die Wirkung inflammatorischer Zytokine und die Veränderung des Tryptophan-Serotonin-Stoffwechsels zurückzuführen. Die Identifizierung individuell relevanter Triggerfaktoren und deren Expositionsvermeidung ist daher gerade auch vor dem klinischen Hintergrund einer depressiven Symptomatik eine wichtige Aufgabe der ganzheitlichen Zahnmedizin.

 

  • Literatur

  • 1 Maes M et al. Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. Neuro Endocrinol Lett 2011; 32: 7-24
    PubMedGoogle Scholar
  • 2 Pall ML. Explaining unexplained illnesses: Disease Paradigm for Chronic Fatigue Syndrome, Multiple Chemical Sensitivity, Fibromyalgia, Post-Traumatic Stress disorders, gulf war syndrome and others. Informa Healthcare 2007;
    PubMedGoogle Scholar
  • 3 Valentine-Thon et al. LTT-MELISA is clinically relevant for detecting and monitoring metal sensitivity. Neuroendocrinol Lett 2006; 27: 17-24
    PubMedGoogle Scholar
  • 4 Gardner RM et al. Mercury exposure, serum antinuclear/antinucleolar antibodies, and serum cytokine levels in mining populations in Amazonian Brazil: a cross-sectional study. Environ Res 2010; 110: 345-354
    CrossrefPubMedGoogle Scholar
  • 5 Anisman H, Merali Z. Cytokines, stress and depressive illness: brain-immune interactions. Ann Med 2003; 35: 2-11
    CrossrefPubMedGoogle Scholar
  • 6 Capuron L, Miller AH. Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry 2004; 56: 819-824
    CrossrefPubMedGoogle Scholar
  • 7 Bluthé RM et al. Synergy between tumor necrosis factor alpha and interleukin-1 in the induction of sickness behavior in mice. Psychoneuroendocrinol 1994; 19: 197-207
    CrossrefPubMedGoogle Scholar
  • 8 Schiepers OJ G et al. Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 201-217
    CrossrefPubMedGoogle Scholar
  • 9 Utsuyama M, Hirokawa K. Differential expression of various cytokine receptors in the brain after stimulation with LPS in young and old mice. Exp Gerontol 2002; 37: 411-420
    CrossrefPubMedGoogle Scholar
  • 10 Müller N, Schwarz MJ. The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry 2007; 12: 988-1000
    CrossrefPubMedGoogle Scholar
  • 11 Coppen A. The biochemistry of affective disorders. Br J Psychiatry 1967; 113: 1237-1264
    CrossrefPubMedGoogle Scholar
  • 12 Merens et al. The effects of eperimentally lowered serotonin function on emotional information processing and memory in remitted depressive patients. J Psychopharmacol 2008; 22: 653-662
    CrossrefPubMedGoogle Scholar
  • 13 Schröcksnadel K et al. Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta 2006; 364: 82-90
    CrossrefPubMedGoogle Scholar
  • 14 Miura H et al. A link between stress and depression: Shifts in the balance between the kynurenine and serotonin pathways of tryptophan metabolism and the etiology and pathophysiology of depression. Stress 2008; 11: 198-209
    CrossrefPubMedGoogle Scholar
  • 15 Myint AM et al. Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord 2007; 98: 143-151
    CrossrefPubMedGoogle Scholar
  • 16 Turner EH et al. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacol Ther 2006; 109: 325-338
    CrossrefPubMedGoogle Scholar
  • 17 Müller N. COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence. Curr Opin Investig Drugs 2010; 11: 31-42
    PubMedGoogle Scholar
  • 18 Raitala A et al. Association of interferon-gamma +874(T/A) single nucleotide polymorphism with the rate of tryptophan catabolism in healthy individuals. Scand J Immunol 2005; 61: 387-390
    CrossrefPubMedGoogle Scholar
  • 19 Wojcik DP et al. Mercury toxicity presenting as chronic fatigue, memory impairment and depression: diagnosis, treatment, susceptibility, and outcomes in a New Zealand general practice setting (1994–2006). Neuroendocrinol Lett 2006; 27: 415-423
    PubMedGoogle Scholar
  • 20 Breivik et al. Glucocorticoid receptor antagonist RU 486 treatment reduces periodontitis in Fischer 344 rats. J Period Res 2000; 35: 285-290
    CrossrefPubMedGoogle Scholar
  • 21 Reece AS. An intriguing association between dental and mental pathology in addicted and control subjects: a cross-sectional survey. Br Dent J 2008; 205
    PubMedGoogle Scholar